Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
Status unknown · Not applicable · NCT02657707
Conditions: Carotid Artery Stenosis
At a glance
- Research payments reported, 2025
- $95,498
- U.S. investigators named
- 10
- Sites paid
- 9
- Planned or actual enrollment
- 295
About the trial
- Sponsor
- Microvention-Terumo, Inc.
- Tested
- Roadsaver™ Carotid Artery Stent Device (device), Nanoparasol® Embolic Protection System (device)
- Dates
- Started 2016-04-21; completion 2024-05
- Results posted
- Not yet
A prospective, multicenter, single-arm, open label clinical study to evaluate the safety and effectiveness of MicroVention, Inc. Roadsaver™ Carotid Stent System used in conjunction with the Nanoparasol® embolic protection system for the treatment of carotid artery stenosis in patients with elevated risk for adverse events following carotid endarterectomy.
From ClinicalTrials.gov, last updated 2023-02-28. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Microvention, Inc. reported $95,498 in research payments for this study in 2025 (18 payments).
Products named: Hydrocoil Helical
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Mansour H. Assar, M.D. Interventional Cardiology · Prescott, AZ
- Nelson L. Bernardo, M.D. Interventional Cardiology · Washington, DC
- Christian N. Ramsey III, M.D. Neurosurgery · Lexington, KY
- Vikram S. Kashyap, MD Vascular Surgery · Grand Rapids, MI
- Donald V. Heck, MD Radiology · Greensboro, NC
- Mitchell Weinberg, MD Interventional Cardiology · Manhasset, NY
- Yiming A. Yang, MD Cardiology · Brooklyn, NY
- Sahil S. Banka, M.D. Interventional Cardiology · Philadelphia, PA
- William A. Gray, M.D. Interventional Cardiology · Wynnewood, PA
- Michael B. Silva JR., MD General Surgery · Galveston, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- The Feinstein Institutes $60,838
- Novant Health Forsyth Medical Center, NC $16,631
- Uh Cleveland Medical Center, OH $4,300
- Baptist Health Lexington, KY $3,625
- Medstar Health Research Institute $2,700
- Albert Einstein Healthcare Network $2,500
- Lankenau Institute for $2,000
- University of Texas Medical Branch Galveston, TX $2,000
- St Josephs Hospital and Medical Center, AZ $905
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.